Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression

AIDS

Volumn 11, Issue 4, 1997, Pages 423-428

  Khoo, Saye H ^a   Pepper, Lynne ^b   Snowden, Neil ^c   Hajeer, Ali H ^b   Vallely, Pamela ^d   Wilkins, Edmund G L ^a   Mandal, Bibhat K ^a   Ollier, William E R ^b  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HOPE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Genetics; HIV progression; Tumour necrosis factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0031055460     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199704000-00004     Document Type: Article

References (30)

1. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD: Long-term HIV-1 infection without immunologic progression. AIDS 1994, 8:1123-1128.
2. Easterbrook PJ: Non-progression in HIV infection. AIDS 1994, 8:1179-1182.
3. Haynes BF, Pantaleo G, Fauci AS: Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996, 271:324-328.
4. Rabkin CS, Hatzakis A, Griffiths PD, et al.: Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. J Infect Dis 1993, 168:1260-1263.
5. Levy JA: HIV pathogenesis and long-term survival. AIDS 1993, 7:1401-1410.
6. Koot M, Keet IPM, Vos AHV, et al.: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993, 118:681-688.
7. Kaslow RA, Carrington M, Apple R, et, al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 1996, 2:405-411.
8. Detels R, Mann D, Carrington M, et al.: Resistance to HIV may be genetically mediated [letter]. AIDS 1996, 10:102-104.
9. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL: Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993, 16:180-186.
10. Grant SCD, Turner DM, Lamb W, et al.: TNFa linked microsatellite markers and in vitro TNFa response in cardiac transplant recipients. J Heart Lung Transplant 1994, 13 (suppl 1):S64.
11. Pociot F, Briant L, Jonganeel CV, et al.: Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles and the secretion of TNFa and TNFb by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993, 23:224-231.
12. Hajeer AH, Worthington J, Silman AJ, Ollier WER: TNF microsatellite polymorphisms are associated with HLA-DRB1*04 bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996, 39:1109-1114.
13. Steel CM, Beatson D, Cuthbert RJG, et al.: HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1988, i:1185-1188
14. Kaslow RA, Duquesnoy R, Van Raden M, et al.: A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. Lancet 1990, 335:927-930.
15. Brettle RP, McNeil AJ, Burns S, et al.: Progression of HIV: follow-up of Edinburgh injecting drug users with narrow serocon-version intervals in 1983-1985. AIDS 1996, 10:419-430.
16. Sahmoud T, Laurian Y, Gazengel C, Sultan Y, Gautreau C, Costagliola D: Progression to AIDS in French haemophiliacs: association with HLA-B35. AIDS 1993, 7:497-500.
17. Itescu S, Rose S, Dwyer E, Winchester R: Certain HLA-DR5 and DR-6 major histocompatibility class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci USA 1994, 91:11472-11476.
18. Balter M: AIDS research. Cytokines move from the margins into the spotlight. Science 1995, 268: 205-206.
19. Vyakernam A, McKeating J, Meager A, Beverly PC: TNF (α β) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 1990, 4:21-28.
20. Vassalli P: The pathophysiology of tumour necrosis factors. Annu Rev Immunol 1992, 10:411-453.
21. Aukrust P, Liabakk NB, Muller F, Loen E, Espevik T, Froland SS: Serum levels of TNFa and soluble TNF receptors in HIV-1 infection: correlations to clinical, immunologic and virologic parameters. J Infect Dis 1994, 169:420-424.
22. Ho DD, Neumann AU, Perelson AS, et al.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
23. Finkel TH, Fudor-Williams G, Banda NK, et al.: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1995, 1:129-134.
24. Matsuyama I, Kobayashi N, Yamamoto N: Cytokines and HIV infection: is AIDS a tumour necrosis factor disease? AIDS 1991, 5:1405-1417.
25. Sarin A, Conan-Cibotti M, Henkart PA: Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J Immunol 1995, 155:3716-3718.
26. Clerici M, Sarin A, Berzofsky JA, et al.: Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS 1996, 10:603-611.
27. Messer G, Spengler U, Jung MC, et al.: Polymorphic structure of the tumour necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNFb gene correlates with a variant amino acid in position 26 and a reduced level of TNFb production. J Exp Med 1991, 173:209-219.
28. Jonganeel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A: Extensive genetic polymorphism in the tumour necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci USA 1991, 88:9717-9721.
29. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevill HO: Heritable MHC class II differences in production of TNF a: relevance to genetic predisposition to SLE. Proc Natl Acad Sci USA 1990, 87:1233-1237.
30. Dezube BJ, Lederman MM, Spritzler JG, et al.: High dose pentoxifylline in patients with AIDS: inhibition of tumour necrosis factor production. J Infect Dis 1995, 171:1628-1632.